Use of inotuzumab-ozogamicin in a child with Down syndrome and refractory B-cell precursor acute lymphoblastic leukemia

被引：4

作者：

Murillo, Laura ^{[1
]}

Luis Dapena, Jose ^{[1
]}

Velasco, Pablo ^{[1
]}

Diaz de Heredia, Cristina ^{[1
]}

机构：

[1] Hosp Univ Vall dHebron, Serv Oncol & Hematol Pediat, Passeig Vall dHebron 119-129, Barcelona 08035, Spain

来源：

PEDIATRIC BLOOD & CANCER | 2019年 / 66卷 / 04期

关键词：

MINIMAL RESIDUAL DISEASE; PROGNOSTIC-FACTORS; PEDIATRIC-PATIENTS; TRANSPLANTATION;

D O I：

10.1002/pbc.27562

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 50 条

[21] A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation [J].

Izumi, Akihiko ;

Tachibana, Takayoshi ;

Ando, Taiki ;

Tanaka, Masatsugu ;

Kanamori, Heiwa ;

Nakajima, Hideaki .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (01) :69-76

[22] Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia [J].

Zheng, Qingqing ;

Jiang, Chuang ;

Liu, Haiyan ;

Hao, Wenge ;

Wang, Pengfei ;

Huang, Haiying ;

Li, Ziping ;

Qian, Jiabi ;

Qian, Maoxiang ;

Zhang, Hui .

FRONTIERS IN ONCOLOGY, 2020, 10

[23] Blinatumomab for the Treatment of Philadelphia Chromosome-Negative, Precursor B-cell Acute Lymphoblastic Leukemia [J].

Wolach, Ofir ;

Stone, Richard M. .

CLINICAL CANCER RESEARCH, 2015, 21 (19) :4262-4269

[24] Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia [J].

Contreras, Cristina F. ;

Higham, Christine S. ;

Behnert, Astrid ;

Kim, Kailyn ;

Stieglitz, Elliot ;

Tasian, Sarah K. .

PEDIATRIC BLOOD & CANCER, 2021, 68 (01)

[25] FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia [J].

Bouchkouj, Najat ;

Lin, Xue ;

Wang, Xiaofei ;

Przepiorka, Donna ;

Xu, Zhenzhen ;

Purohit-Sheth, Tejashri ;

Theoret, Marc .

ONCOLOGIST, 2022, 27 (10) :892-899

[26] Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia [J].

Locatelli, Franco ;

del Bufalo, Francesca ;

Quintarelli, Concetta .

HAEMATOLOGICA, 2024, 109 (06) :1689-1699

[27] Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis [J].

Stelmach, Patrick ;

Wethmar, Klaus ;

Groth, Christoph ;

Wenge, Daniela V. ;

Albring, Joern ;

Mikesch, Jan-Henrik ;

Schliemann, Christoph ;

Reicherts, Christian ;

Berdel, Wolfgang E. ;

Lenz, Georg ;

Stelljes, Matthias .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10) :E724-E733

[28] Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults [J].

Lee, Kum Ja ;

Chow, Vivian ;

Weissman, Ashley ;

Tulpule, Sunil ;

Aldoss, Ibrahim ;

Akhtari, Mojtaba .

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 :1301-1310

[29] An adult B-cell precursor acute lymphoblastic leukemia with multiple secondary cytogenetic aberrations [J].

Walid AL-Achkar ;

Abdulsamad Wafa ;

Moneeb Abdullah Kassem Othman ;

Faten Moassass ;

Abdulmunim Aljapawe ;

Thomas Liehr .

Molecular Cytogenetics, 7

[30] An adult B-cell precursor acute lymphoblastic leukemia with multiple secondary cytogenetic aberrations [J].

Al-Achkar, Walid ;

Wafa, Abdulsamad ;

Othman, Moneeb Abdullah Kassem ;

Moassass, Faten ;

Aljapawe, Abdulmunim ;

Liehr, Thomas .

MOLECULAR CYTOGENETICS, 2014, 7

← 1 2 3 4 5 →